IP Library Granted Patent US 8,293,265
Granted Patent B2
US 8,293,265 · App. 12/506,165 · Granted Oct 23, 2012

Process for manufacturing chewable dosage forms for drug delivery and products thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,265
App. No.
12/506,165
Granted
Oct 23, 2012
Kind
B2
Abstract

A palatable, soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the soft chews do not require the generation of heat during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.

Claims (32)

1. A process for manufacturing multiple units of an edible soft chewable medication (“soft chewable”) having consistent composition and weight, the method comprising:

(a) providing ingredients for the soft chewable to the mixing chamber of a mixer, wherein the ingredients consist of (i) 0.001 to 75% of an anti-parasiticidal or antibiotic active agent, wherein the active agent is adversely affected by temperatures typically generated by extrusion, is not palatable, or both; and (ii) palatable food grade dry inactive ingredients including at least one each of a flavoring, a binder, a bulking agent, a humectant, an oil and an excipient;

(b) blending the active agent and dry inactive ingredients in the mixing chamber by casting the ingredients against the walls of the mixing chamber space, wherein operation of the low shear mixer causes an edible dry soft chew mixture to be formed having the active ingredient uniformly blended therein;

(c) adding a first softening agent consisting of polyethylene glycol or paraffin wax, together with 1 to 3% w/w of a further softening agent selected from the group consisting of propylene glycol, magnesium stearate, calcium stearate or sodium lauryl sulfate to the dry mixture and blending the ingredients together within the mixer to form a soft chewable mixture having a meat-like texture;

(d) removing the soft chewable mixture from the mixer; and,

(e) molding the edible soft chewable mixture into individual unit masses without need for prior cooling of the chewable mixture or application of compression heat thereto, wherein the unit masses so formed are of consistent weight and active content from unit to unit and are generally more palatable to cats and dogs than tablet dosage forms of the active agent,

wherein no cooking extrusion is performed during practice of the method, and wherein further no water or animal origin ingredients are added to the active agent or mixture during performance of the method.

2. The process according to claim 1 , further comprising the step of preparing a trituration of the active agent with an excipient before the active agent is added to the mixing chamber in step (a).

3. The process according to claim 1 , wherein the softening agent added in step (c) is polyethylene glycol.

4. The process according to claim 1 or claim 2 , further comprising the step (a)′ of coating the active agent with a food grade coating before the active agent is added to the mixing vessel in step (a).

5. The process according to claim 1 , further comprising step (f) wherein the individual unit masses are placed into a pharmaceutically acceptable container.

6. The process according to claim 1 , wherein the inactive ingredients are irradiated or pasteurized.

7. The process according to claim 1 , wherein the flavoring is a soy protein product.

8. The process according to claim 7 , wherein the flavoring is an artificially bacon flavored soy protein powder.

9. The process according to claim 1 , wherein the humectant is glycerol, glycerin or cetyl alcohol.

10. The process according to claim 1 , wherein the pharmaceutically active agent is prepared in a trituration with an excipient.

11. The process according to claim 1 , wherein the pharmaceutically active agent is coated.

12. The process according to claim 1 , further comprising a preservative.

13. The process according to claim 1 , wherein the excipient is at least one of crosprovidone, croscarmellose sodium, cellulose, starch, partially or fully pregelatinized starch, and sodium starch glycolate.

14. The process according to claim 1 , wherein the softening agent comprises polyethylene glycol.

15. The process according to claim 1 , wherein the softening agent further comprises magnesium stearate.

16. The process according to claim 9 , wherein the humectant is glycerin.

17. The process according to claim 13 , wherein the excipient comprises pregelatinized starch.

18. The process according to claim 17 , wherein the excipient further comprises croscarmellose sodium.

19. The process according to claim 1 , wherein the oil is a vegetable oil.

20. The process according to claim 1 , wherein the bulking agent is bran, meal, flour, cereal, fiber, whole grains, vegetables, seeds, gum arabic, pectins, modified starches, alginates, carrageenans, xanthan gums, carboxymethylcellulose, methylcellulose, hycroxyethylcellulose, hydroxypropylcellulose, propylene glycol alginate, polyvinylpyrrolidone, carboxyvinyl polymers, polyethylene oxide polymers, talc, dicalcium phosphate and antacids.

21. The process according to claim 12 , wherein the preservative is potaasium sorbate, sodium benzoate or calcium propionate.

22. The process according to claim 12 , wherein the preservative is a food combination of BHA and BHT anti-oxidants.

23. The process according to claim 1 , wherein the flavoring is at least one of plant proteins, plant oils, carob, peanuts, fruit flavors, sweeteners, herbs and spices.

24. The process according to claim 1 , wherein the binder is at least one of molasses, corn syrup, peanut butter, food gum, starch, honey, maple syrup, sugar and pregelatinzed corn starch.

25. The process according to claim 1 , wherein the active agent is an anti-parasticidal.

26. The process according to claim 25 , wherein the anti-parasitcidal agent is ivermectin.

Assignments (6)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON OCTOBER 29, 2020, AT REEL/FRAME 054217/0148 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0043 →
SECURITY INTEREST Recorded Oct 29, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 054217/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: BAYER HEALTHCARE LLC
To: ELANCO US INC.
Reel/Frame 054023/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2013
From: BAYER B.V.
To: BAYER HEALTHCARE, LLC
Reel/Frame 031561/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2011
From: PIEDMONT PHARMACEUTICALS LLC
To: BAYER B.V.
Reel/Frame 026138/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2010
From: TRIAD SPECIALTY PRODUCTS LLC
To: PIEDMONT PHARMACEUTICALS LLC
Reel/Frame 025027/0447 →